TNFRSF4 and COVID-19: Notably, SI was also found to be significantly higher for both spike (p = 0.0007) and non-spike (p = 0.0054) MPs in response to this (OX40+CD40L+) AIM panel in severe COVID-19 patients compared to the unexposed participants (Figure 4A).